Digital health company iLoF is pioneering an AI platform to accelerate the future of personalized drug discovery and development. Its digital library of disease biomarkers and biological profiles is enabling biotechs and pharmaceutical companies to Read More
Tags :Faber
Abtrace raises £2.1m to transform detection and treatment of long-term conditions 26 August 2021 London, UK – Abtrace, a healthtech start-up which uses machine learning to transform how chronic and long-term health conditions are detected, monitored and treated, Read More